Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00016341Phase 3Terminated
A Phase 3 trial of doxorubicin, cisplatin, paclitaxel, megestrol, tamoxifen in endometrial cancer (EC), sponsored by GOG Foundation. Started May 2001; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00016341.